Novartis India has completed the transaction for the transfer of its Animal Health Division to Elanco India on December 31, 2015. This is pursuant to the approval received from the Foreign Investment Promotion Board, Government of India and the Competition Commission of India.
The company had earlier entered into transaction for transfer of its Animal Health Division as a going concern by way of a slump sale to Elanco India, or another affiliate of Eli Lilly and Company.
Novartis is a world leader in the research and development of products to protect and improve health and well-being. The company has core businesses in pharmaceuticals, vaccines, consumer health, generics, eye care and animal health.
Company Name | CMP |
---|---|
Redington | 185.90 |
Adani Enterprises | 2835.30 |
Amrapali Industries | 18.11 |
Rashi Peripheral | 363.45 |
Compuage Infocom | 2.71 |
View more.. |